课题基金 / 基金详情

Clinical and pharmacogenomic predictors of inter-patient variation in direct acting oral anticoagulant (DOAC) plasma concentrations in real-world patients

Clinical and pharmacogenomic predictors of inter-patient variation in direct acting oral anticoagulant (DOAC) plasma concentrations in real-world patients
真实患者中直接作用口服抗凝剂（DOAC）血浆浓度的患者间差异的临床和药物基因组预测因子
批准号：
338124
负责人：
Kim Richard B
金额：
$36.24万
依托单位：
University of Western Ontario
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-10-01 至 2017-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=338124&lang=en
关键词：
Clinical And Pharmacogenomic Predictors

项目摘要

项目成果

Kim Richard B的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organic Anion Transporting Polypeptide (OATP), P-glycoprotein (P-gp), and Breast Cancer Resistance Protein (BCRP) transporters modulate tamoxifen response during breast cancer therapy
  • 批准号：
    452037
  • 项目类别：
    Operating Grants
  • 资助金额：
    $47.93万
  • 财政年份：
    2021
  • 负责人：
    Kim Richard B
  • 依托单位：
    University of Western Ontario
Integrated Precision Medicine Technology and Approach for Optimal Drug Therapy for Canadians
Best Brains Exchange: ''Canada as a Leader in the Development and Deployment of Precision/Personalized Medicine'' March 23, 2015 in Ottawa, ON.
DSEN Pharmacogenomics of Adverse Reaction Events National Team (DSEN-PREVENT)